Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Ann Fr Anesth Reanim ; 25(8): 815-9, 2006 Aug.
Artigo em Francês | MEDLINE | ID: mdl-16860526

RESUMO

OBJECTIVE: The aim of this study was to evaluate the accuracy of the BNP as a marker of acute cor pulmonale in patients with ARDS. STUDY DESIGN: Prospective clinical trial. PATIENTS AND METHODS: At day 2 or 3 after the onset of the ARDS, an echocardiography was performed. Patients with left ventricular dysfunction were excluded. Right ventricular area (RVA) and RVA/LVA ratio were measured. ACP was defined as RVA/LVA > 0.6 associated with septal dyskinesia. Simultaneously, 5 ml of blood was collected for BNP measurement. RESULTS: 26 patients were studied. BNP levels were higher in 10 patients with ACP: 585.5 [189-4830] vs 145.5 [36.5-346] pg/ml (P=0.01) but in those with creatinine clearance < 90 ml/min: 602 [331-3530] vs 125 [39-189] pg/ml (P=0.007). BNP was correlated with RVA (r=0.5; p=0.01), RVA/LVA ratio (r=0.61; p=0.001), sPAP (r=0.58; p=0.002) and with age, cardiac index and creatinine clearance (r=0.61; p=0.001). In multivariate analysis, BNP was only correlated with creatinine clearance (p=0.03), and RVA (p=0.06). CONCLUSION: In ARDS patients without left ventricular dysfunction, BNP level is more elevated in patients with acute cor pulmonale than patients without cor pulmonale.


Assuntos
Peptídeo Natriurético Encefálico/sangue , Doença Cardiopulmonar/sangue , Doença Cardiopulmonar/etiologia , Síndrome do Desconforto Respiratório/sangue , Síndrome do Desconforto Respiratório/complicações , Doença Aguda , Adulto , Idoso , Envelhecimento/metabolismo , Biomarcadores , Creatinina/urina , Ecocardiografia , Feminino , Hemodinâmica/fisiologia , Humanos , Testes de Função Renal , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Estudos Prospectivos , Doença Cardiopulmonar/diagnóstico por imagem , Respiração Artificial , Função Ventricular Direita/fisiologia
2.
Acta Anaesthesiol Scand ; 50(3): 340-7, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16480468

RESUMO

BACKGROUND: Plasma B-type natriuretic peptide (BNP) assay is recommended as a diagnostic tool in emergency-room patients with acute dyspnea. In the intensive care unit (ICU), the utility of this peptide remains a matter of debate. The objectives of this study were to determine whether cut-off values for BNP and N-terminal-proBNP (NT-proBNP) reliably diagnosed right and/or left ventricular failure in patients with shock or acute respiratory distress, and whether non-cardiac factors led to an increase in these markers. METHODS: Plasma BNP and NT-proBNP levels and echocardiographic parameters of cardiac dysfunction were determined in 41 patients within 24 h of the onset of shock or acute respiratory distress. RESULTS: BNP and NT-proBNP levels were higher in the 25 patients with heart failure than in the other 16 patients: 491.7 +/- 418 pg/ml vs. 144.3 +/- 128 pg/ml and 2874.4 +/- 2929 pg/ml vs. 762.7 +/- 1128 pg/ml, respectively (P < 0.05). In the diagnosis of cardiac dysfunction, BNP > 221 pg/ml and NT-proBNP > 443 pg/ml had 68% and 84% sensitivity, respectively, and 88% and 75% specificity, respectively, but there was a substantial overlap of BNP and NT-proBNP values between patients with and without heart failure. BNP and NT-proBNP were elevated, but not significantly, in patients with isolated right ventricular dysfunction. Patients with renal dysfunction and normal heart function had significantly higher levels of BNP (258.6 +/- 144 pg/ml vs. 92.4 +/- 84 pg/ml) and NT-proBNP (2049 +/- 1320 pg/ml vs. 118 +/- 104 pg/ml) than patients without renal dysfunction. CONCLUSION: Both BNP and NT-proBNP can help in the diagnosis of cardiac dysfunction in ICU patients, but cannot replace echocardiography. An elevated BNP or NT-proBNP level merely indicates the presence of a 'cardiorenal distress' and should prompt further investigation.


Assuntos
Peptídeo Natriurético Encefálico/sangue , Fragmentos de Peptídeos/sangue , Síndrome do Desconforto Respiratório/complicações , Choque/complicações , Disfunção Ventricular Esquerda/diagnóstico , Disfunção Ventricular Direita/diagnóstico , Adulto , Idoso , Feminino , Humanos , Rim/fisiopatologia , Masculino , Pessoa de Meia-Idade , Síndrome do Desconforto Respiratório/sangue , Síndrome do Desconforto Respiratório/fisiopatologia , Choque/sangue , Choque/fisiopatologia
3.
Arch Pediatr ; 9(7): 694-6, 2002 Jul.
Artigo em Francês | MEDLINE | ID: mdl-12162157

RESUMO

UNLABELLED: Methadone is a synthetic narcotic used in opioid dependent situations. Child intoxications are harmful, sometimes responsible for death. CASE REPORT: An one-year-old infant was seen in the emergency room, two hours after accidental methadone ingestion. He presented with coma, myosis and respiratory depression. After intubation, symptoms disappeared with naloxone injection. For maintaining this child safe, naloxone was given by continuous infusion during 48 hours. CONCLUSION: Patients, families and professionals should be informed of the risks of methadone intoxication. Owing to methadone long duration of action, initial injection of naloxone, the specific opioid antagonist, must be followed by continuous infusion.


Assuntos
Metadona/intoxicação , Naloxona/administração & dosagem , Acidentes , Fatores Etários , Emergências , Humanos , Lactente , Masculino , Fatores de Tempo
4.
J Cell Biol ; 152(5): 1107-14, 2001 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-11238465

RESUMO

Spinal muscular atrophy (SMA) is characterized by degeneration of motor neurons of the spinal cord associated with muscle paralysis and caused by mutations of the survival motor neuron gene (SMN). To determine whether SMN gene defect in skeletal muscle might have a role in SMA pathogenesis, deletion of murine SMN exon 7, the most frequent mutation found in SMA, has been restricted to skeletal muscle by using the Cre-loxP system. Mutant mice display ongoing muscle necrosis with a dystrophic phenotype leading to muscle paralysis and death. The dystrophic phenotype is associated with elevated levels of creatine kinase activity, Evans blue dye uptake into muscle fibers, reduced amount of dystrophin and upregulation of utrophin expression suggesting a destabilization of the sarcolemma components. The mutant mice will be a valuable model for elucidating the underlying mechanism. Moreover, our results suggest a primary involvement of skeletal muscle in human SMA, which may contribute to motor defect in addition to muscle denervation caused by the motor neuron degeneration. These data may have important implications for the development of therapeutic strategies in SMA.


Assuntos
Éxons/genética , Músculo Esquelético/metabolismo , Músculo Esquelético/patologia , Atrofia Muscular Espinal/genética , Distrofias Musculares/patologia , Proteínas do Tecido Nervoso/genética , Deleção de Sequência/genética , Animais , Biomarcadores , Tamanho Celular , Creatina Quinase/metabolismo , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico , Proteínas do Citoesqueleto/metabolismo , Distrofina/metabolismo , Azul Evans/metabolismo , Imunofluorescência , Proteínas de Membrana/metabolismo , Camundongos , Neurônios Motores/metabolismo , Neurônios Motores/patologia , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/patologia , Distrofias Musculares/enzimologia , Distrofias Musculares/metabolismo , Junção Neuromuscular/metabolismo , Proteínas de Ligação a RNA , Proteínas do Complexo SMN , Sarcolema/metabolismo , Sarcolema/patologia , Utrofina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...